Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2495976 | 0.89 | — | — | |
| Hydrazine SCHEMBL28036607 | 0.52 | CA4 (0.33) | — | |
| Hydrazine SCHEMBL10894352 | 0.52 | — | — | |
| Hydrazine SCHEMBL7901656 | 0.52 | — | — | |
| Hydrazine SCHEMBL6849117 | 0.52 | — | — | |
| Hydrazine SCHEMBL176918 | 0.52 | — | — | |
| Hydrazine SCHEMBL64482 | 0.52 | — | — | |
| Hydrazine SCHEMBL874414 | 0.52 | — | — | |
| Hydrazine SCHEMBL7743628 | 0.52 | — | — | |
| Hydrochloric Acid SCHEMBL25213260 | 0.45 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115786267-B | Tumor organoid drug resistance model and construction method thereof | 深圳明澳生物科技有限公司 | 2023-05-12 | — | — | CN | disclosed |
| CN-114342741-B | Novel strain of Clostridia tubificans and application thereof | 河北科技师范学院 | 2022-11-25 | — | — | CN | disclosed |
| CN-114342741-A | Novel strain of Clostridia tubificans and application thereof | 河北科技师范学院 | 2022-04-15 | — | — | CN | disclosed |
| US-20200181714-A1 | NOX2 as a Biomarker of Radiotherapy Efficiency in Cancer Patients | INSTITUT GUSTAVE-ROUSSY (FR) | 2020-06-11 | — | — | US | disclosed |
| CN-105441998-A | Palladium plating containing sodium nitrite and tetra-n-propylammonium bromide and plating method thereof | WUXI JIABANG ELECTRIC POWER PIPE FACTORY | 2016-03-30 | — | — | CN | disclosed |
| CN-105420773-A | Palladium electroplating liquid containing tetraphenylantimony bromide and electroplating method of palladium electroplating liquid | WUXI JIABANG ELECTRIC POWER PIPE FACTORY | 2016-03-23 | — | — | CN | disclosed |
| CN-105332021-A | Palladium electroplating solution containing sodium nitrite and tetraphenylarsonium bromide and electroplating method thereof | WUXI JIABANG ELECTRIC POWER PIPE FACTORY | 2016-02-17 | — | — | CN | disclosed |
| CN-105332022-A | Palladium electroplating solution containing sodium nitrite and isopentyltriphenylphosphonium bromide and electroplating method thereof | WUXI JIABANG ELECTRIC POWER PIPE FACTORY | 2016-02-17 | — | — | CN | disclosed |
| CN-101386630-B | Organic electroluminescence device | UDC IRELAND LTD | 2013-07-31 | — | — | CN | disclosed |
| CN-101573142-A | Magnetic nanoparticles for hyperthermia, method for their preparation and use in constructs for pharmacological applications | COLOROBBIA ITALIANA SPA (IT) | 2009-11-04 | — | — | CN | disclosed |
| CN-101386630-A | Organic electroluminescence device | FUJIFILM CORP (JP) | 2009-03-18 | — | — | CN | disclosed |